Welcome to The Breast Cancer Network News

The BCN News provides its 20,000 readers with breaking news on breast cancer treatment and research daily. Along with thousands of breast cancer patients and survivors, The BCN News is read in nearly every major cancer and health organization, all the major breast cancer organizations, and major research laboratories and universities around the world.

For a free trial subscription to The BCN News, sign up here, or use the following Constant Contact subscribe option:

Join Our Mailing List
Email:


Today's News Sponsors

Triple Breast Cancer Foundation Night 4 Pink Young Women and Breast Cancer: The Empowerment Series Save the Girls Tour of Long Beach Island
The Triple Negative Breast Cancer Foundation
Our Inspiration

Understanding Triple Negative Breast Cancer These subtypes of breast cancer are generally diagnosed based upon the presence, or lack of, three "receptors" known to fuel most breast cancers: estrogen receptors, progesterone receptors and human epidermal growth factor receptor 2 (HER2). The most successful treatments for breast cancer target these receptors.

Unfortunately, none of these receptors are found in women with triple negative breast cancer. In other words, a triple negative breast cancer diagnosis means that the offending tumor is estrogen receptor-negative, progesterone receptor-negative and HER2-negative, thus giving rise to the name "triple negative breast cancer." On a positive note, this type of breast cancer is typically responsive to chemotherapy. However, triple negative tumors generally do not respond to receptor targeted treatments, and they can be particularly aggressive, and more likely to recur.

The Triple Negative Breast Cancer Foundation is devoted to finding targeted treatment for triple negative breast cancer. With your help, we will find a cure.

Download a PDF of the Guide to Understanding Triple Negative Breast Cancer, developed in collaboration with Living Beyond Breast Cancer.

For more information on Triple Negative Breast Cancer, our Foundation, or how you can help find a cure, visit: TNBCFoundation.org



BCN News Articles for: July 26, 2014

  • Total darkness during the night is a key to success of breast cancer therapy
  • Circadian and Melatonin Disruption by Exposure to Light at Night Drives Intrinsic Resistance to Tamoxifen Therapy in Breast Cancer
  • Surgical Outcome after Neoadjuvant Chemotherapy and Bevacizumab: Results from the GeparQuinto Study (GBG 44)
  • Sentinel Lymph Node Biopsy in Pregnant Women with Breast Cancer
  • Vitamin C and survival among women with breast cancer: A Meta-analysis
  • Effect of integrating 3D-mammography (digital breast tomosynthesis) with 2D-mammography on radiologists' true-positive and false-positive detection in a population breast screening trial
  • Estrogen receptor, Progesterone receptor, HER2 status and Ki67 index and responsiveness to adjuvant tamoxifen in postmenopausal high-risk breast cancer patients enrolled in the DBCG 77C trial
  • Timing of Infectious Complications Following Breast-Conserving Therapy with Catheter-Based Accelerated Partial Breast Irradiation
  • Lacking Trust in One's Doctor Affects Health of Emotionally Vulnerable Cancer Patients
  • Lower levels of trust in one's physician is associated with more distress over time in more anxiously attached individuals with cancer
  • Genetics of cancer: Non-coding DNA can finally be decoded
  • Putative cis-regulatory drivers in colorectal cancer


Current BCN News subscribers can access the full site, including all of today's articles as well as three years of breast cancer news, by entering their email address below:

Email:
Not a subscriber yet? Sign up now for a free 2-week trial subscription, which includes full site access.

The BCN News: The Cancer News You Need To Know